Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Politics, Policy & Law

Maloney calls on HHS to reduce barriers to monkeypox therapy

Lawmaker contrasts hurdles to access in the U.S. amid push for RCTs for Tpoxx

August 12, 2022 1:16 AM UTC

House Oversight & Reform Chairwoman Carolyn Maloney is urging HHS Secretary Xavier Becerra to improve access to monkeypox therapy Tpoxx by streamlining expanded access protocols.

In an Aug. 10 letter to Becerra, Maloney cites the severity of the outbreak — it’s been declared a public health emergency in the U.S. — and contrasts the regulatory status of Tpoxx tecovirimat in the U.S. with Europe, where the antiviral is authorized or approved. While FDA and CDC have taken measures to streamline expanded access IND protocols, she said that the measures have not reduced hurdles to accessing the therapy. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article